Lexicon Pharmaceuticals
LXRX
#7142
Rank
C$0.70 B
Marketcap
C$1.93
Share price
-1.41%
Change (1 day)
112.21%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Net assets

Net assets on the balance sheet as of September 2025 : C$0.16 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has C$0.16 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lexicon Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$0.20 B69.59%
2023-12-31$C$0.12 B-22.3%
2022-12-31$C$0.15 B9.78%
2021-12-31$C$0.14 B-27.39%
2020-12-31$C$0.19 B30.37%
2019-12-31$C$0.15 B-525.2%
2018-12-31$-C$35.97 Million-141.91%
2017-12-31$C$85.82 M-59.42%
2016-12-31$C$0.21 B-46.66%
2015-12-31$C$0.39 B20.31%
2014-12-31$C$0.32 B81.96%
2013-12-31$C$0.18 B-31.69%
2012-12-31$C$0.26 B-12.39%
2011-12-31$C$0.30 B22.58%
2010-12-31$C$0.24 B43.53%
2009-12-31$C$0.17 B-27.75%
2008-12-31$C$0.23 B-16.71%
2007-12-31$C$0.28 B187.18%
2006-12-31$C$99.54 M-0.35%
2005-12-31$C$99.89 M-31.6%
2004-12-31$C$0.14 B-32.27%
2003-12-31$C$0.21 B-19.65%
2002-12-31$C$0.26 B-22.86%
2001-12-31$C$0.34 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Eterna Therapeutics
ERNA
C$4.93 M-97.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$42.76 B 25,664.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C$22.32 M-86.55%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$8.36 B 4,940.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$70.66 B 42,471.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-C$0.63 Billion-475.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$3.28 B 1,881.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$1.31 B 690.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-C$0.23 Billion-236.47%๐Ÿ‡บ๐Ÿ‡ธ USA